The Food and Drug Administration (FDA) announced in early July it has approved the Implantable Miniature Telescope (IMT) to improve vision in some patients with end-stage, age-related macular degeneration (AMD). When surgically implanted in one eye, the IMT, the replaces the patient’s natural lens and provides an image that has been magnified more than two [Sign in to read the full article...]